CURE’s childhood cancers page is a go-to resource for oncology news and updates in the world of childhood cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in childhood cancers.
November 12th 2024
Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.
FDA Approves Tasigna for Pediatric CML
March 22nd 2018Tasigna (nilotinib) was granted Food and Drug Administration (FDA) approval, to be used in the first- and second-line setting for pediatric patients 1 year old or older who have Philadelphia chromosome–positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP).
Childhood Pneumonia May Be Associated With Cancer Risk
February 2nd 2018While causes for pneumonia were varied – including bacteria (14 percent), virus (22 percent) and unspecified (64 percent) – the majority of children did not have immune deficiencies recorded at the time of their pneumonia diagnosis.
We Can. I Can. How One Innovator Is Working to Bring HOPE to Pediatric Patients With Cancer
February 2nd 2018The children’s app is paired with a complementary parent and caregiver-focused platform and guide that helps drive conversations about disease and treatment, timed to the child’s progression and in language that aligns with the game.
Childhood Cancer Survivors at Increased Risk for High Blood Pressure
December 23rd 2017Approximately 420,000 Americans are adult survivors of childhood cancer, and these individuals may be twice as likely to have high blood pressure, also known as hypertension, according to researchers at St. Jude Children’s Research Hospital.
Addressing the Psychosocial Side of Childhood Cancer
December 8th 2017The Mattie Miracle Cancer Foundation is dedicated to addressing the psychological needs of children and families with childhood cancer. It also aims to educate health care providers about potential psychosocial effects of a diagnosis.
Sprycel Approved for CML Subset
November 10th 2017Sprycel (dasatinib), an oral medication that helps reduce the production of damaged white blood cells, has been approved by the Food and Drug Administration for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Using Playtime to Avoid Anesthesia in Children With Cancer
June 29th 2017When pediatric patients are given radiation treatment for cancer, they often get scared or nervous because they do not have an understanding of the process and the machines involved. To remedy this, anesthesia is used in many cases, though the long-term side effects are still unknown.
Despite Benefits, HPV Vaccination Rates Remain Too Low
May 18th 2017Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
Blincyto FDA Approved for Pediatric Acute Lymphoblastic Leukemia
September 2nd 2016The FDA has approved Blincyto (blinatumomab) for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).